Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, wherein R1 is an optionally substituted phenyl, or an optionally substituted 5- or 6-membered aromatic heterocycle; and R2 is an optionally substituted 5- or 6-membered aromatic heterocycle. Also provided are pharmaceutical compositions comprising a compound of formula (I).
Type:
Application
Filed:
September 8, 2023
Publication date:
April 4, 2024
Applicants:
EXSCIENTIA LTD.,, EVOTEC INTERNATIONAL GMBH
Inventors:
Andrew Simon BELL, Adrian Michael SCHREYER, Stephanie VERSLUYS
Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, wherein R1 is an optionally substituted phenyl, or an optionally substituted 5- or 6-membered aromatic heterocycle; and R2 is an optionally substituted 5- or 6-membered aromatic heterocycle. Also provided are pharmaceutical compositions comprising a compound of formula (I).
Type:
Grant
Filed:
June 4, 2019
Date of Patent:
October 17, 2023
Assignees:
EXSCIENTIA LTD., EVOTEC INTERNATIONAL GMBH
Inventors:
Andrew Simon Bell, Adrian Michael Schreyer, Stephanie Versluys
Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, wherein R1 is an optionally substituted phenyl, or an optionally substituted 5- or 6-membered aromatic heterocycle; and R2 is an optionally substituted 5- or 6-membered aromatic heterocycle. Also provided are pharmaceutical compositions comprising a compound of formula (I).
Type:
Application
Filed:
June 4, 2019
Publication date:
August 19, 2021
Applicants:
EXSCIENTIA LTD.,, EVOTEC INTERNATIONAL GMBH
Inventors:
Andrew Simon BELL, Adrian Michael SCHREYER, Stephanie VERSLUYS